Clinical trial · on the rundown Wednesday, February 18, 2026
Zealand Pharma reports positive Phase 1a results for ZP9830
Covered by 2 outlets over 7 hours. First reported by manilatimes.net at 07:00 UTC on February 18, 2026.
- outlets2
- distinct reports2
- first to latest report7 h
- names in it3
What happened?
- Zealand Pharma announced positive Phase 1a topline results with Kv1.3 channel blocker ZP9830, according to manilatimes.net.
- Zealand Pharma reported positive Phase 1a results for Kv1.3 channel blocker ZP9830, according to rttnews.com.
Zealand Pharma announced positive Phase 1a topline results for its Kv1.3 channel blocker ZP9830, according to the reports.
A machine summary written from the reports listed below; read them for the full account. How summaries are made and what is checked.
Who reported it, and when?
| Time | Report | Run by |
|---|---|---|
| Feb 18 07:00 | Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830 |
|
| Feb 18 13:45 | Zealand Pharma Reports Positive Phase 1a Results For Kv1.3 Channel Blocker ZP9830 |
|
Who was named?
- Zealand Pharma
- Kv1.3 channel blocker
- ZP9830
Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).